Literature DB >> 10617204

Transmissible and genetic prion diseases share a common pathway of neurodegeneration.

R S Hegde1, P Tremblay, D Groth, S J DeArmond, S B Prusiner, V R Lingappa.   

Abstract

Prion diseases can be infectious, sporadic and genetic. The infectious forms of these diseases, including bovine spongiform encephalopathy and Creutzfeldt-Jakob disease, are usually characterized by the accumulation in the brain of the transmissible pathogen, an abnormally folded isoform of the prion protein (PrP) termed PrPSc. However, certain inherited PrP mutations appear to cause neurodegeneration in the absence of PrPSc, working instead by favoured synthesis of CtmPrP, a transmembrane form of PrP. The relationship between the neurodegeneration seen in transmissible prion diseases involving PrPSc and that associated with ctmPrP has remained unclear. Here we find that the effectiveness of accumulated PrPSc in causing neurodegenerative disease depends upon the predilection of host-encoded PrP to be made in the ctmPrP form. Furthermore, the time course of PrPSc accumulation in transmissible prion disease is followed closely by increased generation of CtmPrP. Thus, the accumulation of PrPSc appears to modulate in trans the events involved in generating or metabolising CtmPrP. Together, these data suggest that the events of CtmPrP-mediated neurodegeneration may represent a common step in the pathogenesis of genetic and infectious prion diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10617204     DOI: 10.1038/45574

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  88 in total

1.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Substrate-specific regulation of the ribosome- translocon junction by N-terminal signal sequences.

Authors:  D T Rutkowski; V R Lingappa; R S Hegde
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Molecular changes of preclinical scrapie can be detected by infrared spectroscopy.

Authors:  Janina Kneipp; Michael Beekes; Peter Lasch; Dieter Naumann
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

4.  Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; I Zaitsev; P Koni; Z Y Lu; R A Flavell; W Fritch
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel.

Authors:  Soo Jung Kim; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

6.  Genetic variability of the coding region for the prion protein gene (PRNP) in gayal (Bos frontalis).

Authors:  Dongmei Xi; Qing Liu; Jianhong Guo; Hongman Yu; Yuai Yang; Yiduo He; Huaming Mao; Xiao Gou; Weidong Deng
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

Review 7.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

Review 8.  Understanding the biogenesis of polytopic integral membrane proteins.

Authors:  R J Turner
Journal:  J Membr Biol       Date:  2003-04-01       Impact factor: 1.843

Review 9.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

10.  In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.

Authors:  Joëlle Chabry; Christiane Ratsimanohatra; Isabelle Sponne; Pierre-Paul Elena; Jean-Pierre Vincent; Thierry Pillot
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.